NovaBay Pharmaceuticals reported a net loss of $2.4 million, or $0.16 per share, for the third quarter of 2017 compared with a net loss of $3.7 million, or $0.34 per share, for the third quarter of 2016.
Net sales for the quarter rose from $3.4 million to $4.1 million, according to a company press release.
Sales and marketing expenses increased from $2.7 million in 2016’s third quarter to $3.3 million in the third quarter of 2017, which was attributed to an increase in the number of sales representatives and increased (Read more...)
Uncategorized